Hand-assisted Laparoscopic Surgery for Colorectal Liver Metastasis: Analysis of Short-term and Long-term Results. Issue 5 (31st October 2021)

• Record Type: Journal Article
• Authors: Mahamid, Ahmad; Sawaied, Munier; Berger, Yael; Halim, Nasser A.; Goldberg, Natalia; Abu-Zaydeh, Omar; Bitterman, Arie; Sadot, Eran; Haddad, Riad
• Is Part Of: Surgical laparoscopy endoscopy & percutaneous techniques. Volume 31:Issue 5(2021)
• Page Start: 543
• Page End: 549
• Publication Date: 2021-10-31
• Subjects: hand-assisted laparoscopic surgery -- liver resection -- colorectal liver metastases; Endoscopic surgery -- Periodicals; Laparoscopic surgery -- Periodicals; Endoscopy -- Periodicals; Laparoscopy -- Periodicals; 617.550597
• DOI: 10.1097/SLE.0000000000000931
• Languages: English
• ISSNs: 1530-4515

Abstract

Abstract : Background: There is scant data regarding the outcomes of hand-assisted laparoscopic surgery (HALS) for colorectal liver metastasis (CRLM). The aim of this study is to report our experience and analyze the short-term and long-term results. Materials and Methods: Retrospective study of patients undergoing HALS for CRLM in 2 university affiliated medical centers. Results: Two hundred and thirty-eight liver procedures were performed on 145 patients including 205 parenchymal sparing resections and 33 anatomic resections. The median number of metastases was 1 (range: 1 to 8), 38 patients (26.2%) had 3 or more metastases, and 41 patients (28.3 had a bi-lobar disease. The tumor size was 20 (2 to 90) mm, and 52 patients (36.6%) had a tumor larger than 30 mm. Nighty-nine patients (67.8%) received neoadjuvant chemotherapy. In 8 patients (5.5%) the laparoscopic liver resection was combined with ablation, and 16 patients (11%) underwent a synchronous resection of colorectal cancer. The median operative time, blood loss during surgery, and postoperative hospital stay were 163 minutes, 300 mL, and 4 days, respectively. The median modified Iwate complexity score was 4 (0 to 10) and the conversion rate to open surgery was 5.5%. The overall and major complication rates were 23.8% and 3.6%, respectively. The mortality rate was 0.7%. R0 resections were achieved in 91% of patients. Median overall survival for all the cohort (intend to treat) was 59 months, and the 8- and 10-year overall survival rates were 47.3% and 24.9%, respectively. Conclusions: This study shows that HALS is a safe and efficacious treatment for selected patients with CRLM.